2023
Persistent Hypoxemia in an Asymptomatic 4-year-old Boy.
Brumer E, de Ángel Solá D, Hogan M, Chen L. Persistent Hypoxemia in an Asymptomatic 4-year-old Boy. Pediatrics In Review 2023, 44: 290-293. PMID: 37122046, DOI: 10.1542/pir.2021-005293.Peer-Reviewed Original Research
2021
The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question
O'Brien SH, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan M, Luchtman‐Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatric Blood & Cancer 2021, 68: e28967. PMID: 34047047, DOI: 10.1002/pbc.28967.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHealth care providersAsymptomatic childrenHematologic testsFamily historyCare providersRed blood cell transfusionChoosing Wisely projectProphylaxis of childrenBlood cell transfusionPediatric Hematology/OncologyGranulocyte colony-stimulating factorChoosing Wisely campaignHistory of recurrentChoosing Wisely recommendationsIron deficiency anemiaPositive family historyHematology/oncologyQuality improvement initiativesAmerican SocietyColony-stimulating factorInternal Medicine FoundationAutoimmune neutropeniaActive bleedingCell transfusionPlatelet transfusions
2018
Parental perception of child vulnerability in childhood cancer survivors
Hogan M, Ross WL, Balsamo L, Mitchell H, Kadan‐Lottick N. Parental perception of child vulnerability in childhood cancer survivors. Pediatric Blood & Cancer 2018, 65: e27364. PMID: 30024087, DOI: 10.1002/pbc.27364.Peer-Reviewed Original ResearchConceptsChildhood cancer survivorsCancer survivorsLate complicationsCancer historyPercent of parentsCurrent health statusCurrent mean ageChild Vulnerability ScalePatient sociodemographicsClinic visitsCohort studySurvivorship clinicPediatric patientsTherapy completionYears posttherapyMean ageMedical recordsLower riskHealth statusComplicationsChild vulnerabilityCancer treatmentSurvivorsTreatment intensityCancer diagnosis
2016
Navigating your career path in pediatric hematology/oncology: On and off the beaten track
Zweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer 2016, 63: 1723-1730. PMID: 27295503, DOI: 10.1002/pbc.26094.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2015
Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia
Honarpisheh H, Hogan M, Rinder HM, Siddon AJ. Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia. Journal Of Pediatric Hematology/Oncology 2015, 37: 472-473. PMID: 26181419, DOI: 10.1097/mph.0000000000000357.Peer-Reviewed Case Reports and Technical Notes
2012
New health conditions identified at a regional childhood cancer survivor clinic visit
Hogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.Peer-Reviewed Original ResearchConceptsNew health conditionsClinic visitsSurvivorship clinicChildhood cancerHealth conditionsOdds ratioChildren's Oncology Group Long-Term FollowCancer treatment exposuresRegular medical careCancer diagnosisPotential treatment-related effectsLong-term followCancer survivorship clinicTherapy-related effectsTreatment-related effectsRisk-based screeningGroup of survivorsSurvivor clinicChest irradiationPulmonary dysfunctionSubsequent cancerLate complicationsNeurologic impairmentAssociated FactorsMultivariate regression model